2019/09/26 Journal Club
Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status. (PubMed Link)
2019/09/26 Journal Club Read More »
Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status. (PubMed Link)
2019/09/26 Journal Club Read More »
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade. (PubMed Link)
2019/03/21 Journal Club Read More »
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells. (PubMed Link)
2018/07/19 Journal Club Read More »
Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy. (PubMed Link)
2018/03/01 Journal Club Read More »
Identification of an atypical monocyte and committed progenitor involved in fibrosis. (PubMed Link) Yi-Hong Slide 瀏覽或下載連結 買一送一 ^^ CCR2+ monocytic myeloid-derived suppressor cells (M-MDSCs) inhibit collagen degradation and promote lung fibrosis by producing transforming growth factor-β1. (PubMed Link)
2017/11/02 Journal Club Read More »
Enrichment of Human CCR6+ Regulatory T Cells with Superior Suppressive Activity in Oral Cancer. (PubMed Link) Yi-Hong’s slides : 按我預覽或下載
2017/07/20 Journal Club Read More »
PI3Kγ is a molecular switch that controls immune suppression. (PubMed Link) ————————Yi-Hongのslides <按我預覽或下載> 2017/06/26 Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells 講者:許銘娟 博士 ( Dr.洪副實驗室博士後研究員 後來颱風取消)
2017/04/27 Journal Club Read More »
Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer. < PubMed 連結> PMID: 27713748 ——————————————————————————–奕宏報告的PPT檔 按我預覽或下載 奕宏補充報告PPT檔 按我預覽或下載
2017/02/02 Journal Club paper Read More »
由 natsumi 在 四, 09/18/2014 – 14:58 發表 Pre-published IDO1 #1由 sufang 在 五, 10/24/2014 – 14:50 發表。Dr. George Prendergast’s visit Time: 10:00~11:30 October 24, 2014 (Fri) Topic: IDO pathways in pathogenic inflammation and immune escape in cancer Speaker: George C. Prendergast, PhD (CV download) Professor, President & CEO, Lankenau Institute for Medical Research
IDO1 expression in OSCC Read More »